University Department of Psychiatry, Warneford Hospital, Oxford
Department of Pharmacology, South Parks Road, Oxford
University Department of Psychiatry, Warneford Hospital, Oxford
Correspondence: Dr S. F. B. McTavish, Neurosciences Building, Warneford Hospital, Oxford OX37JX, UK. Tel: 01865 223612; Fax: 01865 251076; E-mail: sarah.mctavish{at}psychiatry.oxford.ac.uk
Declaration of interest The study was supported by a grant from the Wellcome Trust to M.H.M. M.H.M. was a Nuffield Research Fellow, S.F.B.M. was an MRC Clinical Training Fellow and P.J.C. and T.S. are MRC Clinical Scientists.
Background In rats, amino acid mixtures lacking tyrosine and its precursor phenylalanine decrease the release of dopamine produced by the psychostimulant drug amphetamine. Amphetamine has been proposed as a model for clinical mania.
Aims To assess whether dietary tyrosine depletion attenuates the psychostimulant effects of methamphetamine in healthy volunteers and diminishes the severity of mania in acutely ill patients.
Method Sixteen healthy volunteers received a tyrosine-free amino acid mixture and a control mixture in a double-blind crossover design 4 h before methamphetamine (0.15 mg/kg). Twenty in-patients meeting DSMIV criteria for mania were allocated blindly and randomly to receive either the tyrosine-free mixture or the control mixture.
Results The tyrosine-free mixture lowered both subjective and objective measures of the psychostimulant effects of methamphetamine. Ratings of mania were lower in the patients who received the tyrosine-free mixture.
Conclusions Decreased tyrosine availability to the brain attenuates pathological increases in dopamine neurotransmission following methamphetamine administration and putatively in mania.
Related articles in BJP:
This article has been cited by other articles:
![]() |
A Hrobjartsson, E Forfang, M. Haahr, B Als-Nielsen, and S Brorson Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding Int. J. Epidemiol., June 1, 2007; 36(3): 654 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fernstrom and M. H. Fernstrom Tyrosine, Phenylalanine, and Catecholamine Synthesis and Function in the Brain J. Nutr., June 1, 2007; 137(6): 1539S - 1547S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Lythe, I. M. Anderson, J. F. W. Deakin, R. Elliott, and P. L. Strickland Lack of behavioural effects after acute tyrosine depletion in healthy volunteers J Psychopharmacol, January 1, 2005; 19(1): 5 - 11. [Abstract] [PDF] |
||||
![]() |
B. J. Harrison, J. S. Olver, T. R. Norman, G. D. Burrows, K. A. Wesnes, and P. J. Nathan Selective Effects of Acute Serotonin and Catecholamine Depletion on Memory in Healthy Women J Psychopharmacol, March 1, 2004; 18(1): 32 - 40. [Abstract] [PDF] |
||||
![]() |
A. J. Montgomery, S. F.B. McTavish, P. J. Cowen, and P. M. Grasby Reduction of Brain Dopamine Concentration With Dietary Tyrosine Plus Phenylalanine Depletion: An [11C]Raclopride PET Study Am J Psychiatry, October 1, 2003; 160(10): 1887 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. SCARNA, H. J. GIJSMAN, S. F. B. McTAVISH, C. J. HARMER, P. J. COWEN, and G. M. GOODWIN Effects of a branched-chain amino acid drink in mania The British Journal of Psychiatry, March 1, 2003; 182(3): 210 - 213. [Abstract] [Full Text] [PDF] |
||||